MYL

Mylan Inc. News Headlines

$57.51
*  
0.68
1.2%
Get MYL Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
How traders are protecting Mylan
12/19/2014 6:16:03 AM - optionMONSTER


Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog
12/18/2014 7:07:00 PM - Zacks.com


Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog
12/18/2014 7:07:00 AM - Investopedia


Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog
12/16/2014 6:20:00 PM - Zacks.com


Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog
12/16/2014 6:20:00 AM - Investopedia


Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog
12/12/2014 5:20:00 PM - Zacks.com


Actavis Likely to Continue Selling Namenda IR Tablets - Analyst Blog
12/12/2014 3:20:00 PM - Zacks.com


Mylan Among First to Launch Generic Celebrex - Analyst Blog
12/11/2014 4:22:00 PM - Zacks.com


Supernus Faces another Patent Challenge for Oxtellar XR - Analyst Blog
12/11/2014 3:20:00 PM - Zacks.com


Health Care Sector Update for 12/11/2014: ARIA, STJ, KITE, MYL
12/11/2014 8:52:38 AM - MT Newswires


Mylan Launches Generic Version Of Muscle Relaxant Drug
12/11/2014 7:42:00 AM - RTT News


Mylan Announces Launch Of First Generic Version Of Orapred ODT - Quick Facts
12/11/2014 7:08:00 AM - RTT News


Supernus Faces New Patent Challenge for Trokendi XR - Analyst Blog
12/10/2014 2:50:00 PM - Zacks.com


Nasdaq 100 Movers: VIP, GMCR
12/10/2014 12:16:06 PM - BNK Invest


Health Care Sector Update for 12/10/2014: MYL, AKER, NVDQ
12/10/2014 8:29:26 AM - MT Newswires


Mylan Launches Celecoxib Capsules, 50 Mg, 100 Mg, 200 Mg, 400 Mg - Quick Facts
12/10/2014 7:39:00 AM - RTT News


Mylan Launches Celecoxib Capsules, 50 Mg, 100 Mg, 200 Mg, 400 Mg - Quick Facts
12/10/2014 7:39:00 AM - RTT News


Generic EpiPen Could Give These 2 Stocks A Jolt Of Adrenaline
12/8/2014 4:48:00 PM - Seeking Alpha


3 Cheap Dividend Stocks That Could Be Top Stocks in 2015
12/8/2014 8:15:03 AM - Motley Fool


CLRB Spikes Over 13%, OVAS In Good Health, INCY, MYL Get FDA Nod
12/5/2014 12:20:00 AM - RTT News


Mylan : Tentative FDA Approval For Pediatric Formulations Of Abacavir/lamivudine
12/4/2014 10:11:00 AM - RTT News


Mylan, Gilead Ink Deal for TAF-based HIV Drugs - Analyst Blog
12/2/2014 5:45:00 PM - Zacks.com


Teva First to Launch a Generic of Novartis' Exforge HCT - Analyst Blog
12/2/2014 4:30:00 PM - Zacks.com


Mylan Signs Deal With Gilead To Enhance Access To TAF-based HIV Treatments
12/1/2014 8:57:00 AM - RTT News


Mylan (MYL) Sued By Baxter for Generic Filing of Brevibloc - Analyst Blog
11/28/2014 4:30:00 PM - Zacks.com